Tech Company Financing Transactions
InStride Health Funding Round
InStride Health, based in Boston, secured $30 million in investment from General Catalyst, .406 Ventures and Hopelab.
Transaction Overview
Company Name
Announced On
3/27/2024
Transaction Type
Venture Equity
Amount
$30,000,000
Round
Series B
Investors
General Catalyst (Lead Investor) (Holly Maloney)
Proceeds Purpose
The new capital enables InStride Health to continue investing in clinical quality while expanding to new markets.
Company Information
Company Status
Private & Independent
Industry
InsureTech
Mailing Address
Undisclosed
Boston, MA Undisclosed
USA
Boston, MA Undisclosed
USA
Phone
Website
Email Address
Overview
InStride Health was formed with a clear vision in mind: To help solve the pediatric mental health crisis. After almost two decades in the Harvard Medical system, Drs. Potter and Boger joined John Voith and Jaimie McElhiney in co-founding InStride to ensure that all families struggling with moderate to severe anxiety and/or OCD have access to research-backed, convenient treatment that works. Together, they're helping take the best of the academic and technology worlds to ensure treatment is engaging and high impact.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Voith
Chief Technical Officer
James McElhiney
Co-Founder
Kathryn Boger
Co-Founder
Mona Potter
Browse more venture capital transactions:
Prev: 3/27/2024: Elixir Games venture capital transaction
Next: 3/27/2024: TCab Tech venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document tech company VC transactions. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs